Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease
- PMID: 19276266
- PMCID: PMC2991083
- DOI: 10.1158/1078-0432.CCR-08-2332
Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease
Abstract
Purpose: We have shown previously that oral feeding of green tea polyphenols (GTP) to transgenic adenocarcinoma of the mouse prostate mice in a purely chemopreventive setting significantly inhibits prostate cancer development. To translate this to a human situation, the present study was designed to identify the stage of prostate cancer that is most vulnerable to chemopreventive intervention by GTP.
Experimental design: GTP infusion (0.1% in drinking water) to transgenic adenocarcinoma of the mouse prostate was initiated at ages representing different stage of the disease: (a) 6 weeks (group 1, normal prostate), (b) 12 weeks (group 2, prostatic intraepithelial neoplasia), (c) 18 weeks (group 3, well-differentiated adenocarcinoma), and (b) 28 weeks (group 4, moderately differentiated adenocarcinoma). At age 32 weeks, subsets of animals were evaluated by magnetic resonance imaging, ultrasound, and prostate weight and for serum insulin-like growth factor (IGF)-I/IGF binding protein-3 and IGF signaling.
Results: Tumor-free survival was extended to 38 weeks (P < 0.001) in group 1, 31 weeks (P < 0.01) in group 2, and 24 weeks (P < 0.05) in group 3 compared with 19 weeks in water-fed controls. Median life expectancy was 68 weeks in group 1, 63 weeks in group 2, 56 weeks in group 3, and 51 weeks in group 4 compared with 42 weeks in the control mice. IGF-I and its downstream targets including phosphatidylinositol 3-kinase, pAkt, and phosphorylated extracellular signal-regulated kinase were significantly inhibited only when intervention was initiated early when prostatic intraepithelial neoplasia lesions were common.
Conclusions: Our studies indicate that chemopreventive potential of GTP decreases with advancing stage of the disease and underscore the need to design appropriate chemoprevention clinical trails.
Conflict of interest statement
No potential conflicts of interest were disclosed.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2991083/bin/nihms251985f1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2991083/bin/nihms251985f2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2991083/bin/nihms251985f3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2991083/bin/nihms251985f4.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2991083/bin/nihms251985f5.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2991083/bin/nihms251985f6.gif)
Similar articles
-
Chemopreventive effects of tea in prostate cancer: green tea versus black tea.Mol Nutr Food Res. 2011 Jun;55(6):905-20. doi: 10.1002/mnfr.201000648. Epub 2011 May 2. Mol Nutr Food Res. 2011. PMID: 21538852 Free PMC article. Review.
-
Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies.Nutr Cancer. 2009;61(6):836-41. doi: 10.1080/01635580903285056. Nutr Cancer. 2009. PMID: 20155624 Free PMC article. Review.
-
Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model.Pharm Res. 2008 Sep;25(9):2135-42. doi: 10.1007/s11095-008-9553-z. Epub 2008 Mar 4. Pharm Res. 2008. PMID: 18317887 Free PMC article.
-
Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.Cancer Res. 2004 Dec 1;64(23):8715-22. doi: 10.1158/0008-5472.CAN-04-2840. Cancer Res. 2004. PMID: 15574782
-
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10350-5. doi: 10.1073/pnas.171326098. Epub 2001 Aug 14. Proc Natl Acad Sci U S A. 2001. PMID: 11504910 Free PMC article.
Cited by
-
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase.Front Pharmacol. 2024 Jan 11;14:1231671. doi: 10.3389/fphar.2023.1231671. eCollection 2023. Front Pharmacol. 2024. PMID: 38273823 Free PMC article.
-
Inhibitory effects of mixed flavonoid supplements on unraveled DSS-induced ulcerative colitis and arthritis.Bioimpacts. 2023;13(1):73-84. doi: 10.34172/bi.2022.23523. Epub 2022 Dec 31. Bioimpacts. 2023. PMID: 36817000 Free PMC article.
-
Potential of green tea EGCG in neutralizing SARS-CoV-2 Omicron variant with greater tropism toward the upper respiratory tract.Trends Food Sci Technol. 2023 Feb;132:40-53. doi: 10.1016/j.tifs.2022.12.012. Epub 2022 Dec 28. Trends Food Sci Technol. 2023. PMID: 36594074 Free PMC article. Review.
-
Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome.Cancers (Basel). 2022 Aug 18;14(16):3988. doi: 10.3390/cancers14163988. Cancers (Basel). 2022. PMID: 36010981 Free PMC article. Review.
-
Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer.Front Pharmacol. 2022 Jul 4;13:906746. doi: 10.3389/fphar.2022.906746. eCollection 2022. Front Pharmacol. 2022. PMID: 35860020 Free PMC article. Review.
References
-
- Syed DN, Khan N, Afaq F, Mukhtar H. Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev. 2007;16:2193–203. - PubMed
-
- Adhami VM, Mukhtar H. Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer. Mol Biotechnol. 2007;37:52–7. - PubMed
-
- Boyle P, Severi G. Epidemiology of prostate cancer chemoprevention. Eur Urol. 1999;35:370–6. - PubMed
-
- Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000;85:60–7. - PubMed
-
- Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411:390–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical